Accueil   Diary - News   All news Biom'Up completes the first of its financing operations for a total amount of more than €40 million

Biom’Up completes the first of its financing operations for a total amount of more than €40 million

  • €16 million capital increase completed successfully by means of a public offering without preferential subscription rights
  • Biom'Up aims to complete its second financing transaction by finalizing, as soon as possible, a bond issue with Athyrium Capital
  • Management for an initial amount of €25 million which may subsequently be increased to €35 million
  • The proposed bond issue will enable the company to refinance the Kreos Capital loan of €8.2 million

     

 

 

 

Saint-Priest, France, February 20, 2018 – 7.00 a.m. Paris time – Biom’Up (the “Company”), a specialist in surgical hemostasis, announces today the success of its capital increase without preferential subscription rights for shareholders by means of a public offering and with a priority subscription period, as of right only, for existing shareholders (the “Offering”), in a total amount (including additional paid-in capital) of €16 million. Athyrium Capital Management (“Athyrium”) has confirmed it is participating in the Offering and efforts are underway to finalize the €25 million bond issue (the “Bond Issue”) with stock warrants, the size of which may subsequently be increased to €35 million.

 

Read the press release